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Pediatric sleep disordered breathing has emerged in the last few decades as a highly
prevalent condition by virtue of its major morbidities encompassing the central nervous,
cardiovascular, and metabolic systems. In this context, improved understanding of the
pathophysiological mechanisms underlying the cellular and organ injury and repair mech-
anisms, and the variance of the phenotype at any level of disease severity is all the more
critical if appropriate personalized therapies are to be developed in the future. In this paper,
the current evidence and hypothetical framework pointing to the endothelium as a primary
cellular target for many of the morbidities of pediatric sleep apnea is reviewed, and par-
ticular emphasis on the recruitment of the endothelial cell lineage will be explored. It is
hoped that this perspective will foster both expansion and acceleration of discovery efforts
aiming to ultimately prevent the potentially lifelong consequences of sleep apnea during
childhood.
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INTRODUCTION
The frequent presence of academic, behavioral and cognitive difﬁ-
culties in childrenwith sleep disordered breathing (SDB) has led to
greatly increased awareness to this condition. In recent years, the
cardiovascular system has been more systematically explored in
the context of SDB, and the endothelium has emerged as a major,
if not the major cellular target for injury in this disease. In this
review, I will discuss the evidence linking pediatric sleep apnea to
endothelial dysfunction.
OSA IN CHILDREN
Habitual snoring during sleep, the hallmark indicator of increased
upper airway resistance, is an extremely frequent occurrence dur-
ing early childhood,with a prevalence of up to 27% being reported
(median 12%; Hultcrantz et al., 1995; Ferreira et al., 2000; O’Brien
et al., 2003; Rosen et al., 2003; Ersu et al., 2004; Kaditis et al.,
2004; Montgomery-Downs et al., 2004; Urschitz et al., 2004;
Montgomery-Downs and Gozal, 2006).
The spectrum of the condition termed “sleep disordered
breathing” in children is difﬁcult to deﬁne in a precise fashion
because the cut-offs of what constitutes disease or not is still the
subject of intense debate (Gozal and Kheirandish-Gozal, 2010;
Spruyt et al., 2010). Notwithstanding of such elusive diagnos-
tic criteria, obstructive sleep apnea (OSA) is most common in
young children (pre-school and early school years) with a peak
prevalence around 2–8 years, and subsequent declines in frequency
(Corbo et al., 2001).In children, the two major pathophysiological
determinants of OSA are enlargement of tonsils and adenoids and
obesity. Indeed, the rather accelerated increase over the last two
decades in the prevalence of pediatric obesity has led to substantial
changes in the cross sectional demographic and anthropomet-
ric characteristics of the children being referred for evaluation of
habitual snoring. For example, while <15% of all symptomatic
habitually snoring children were obese (i.e., body-mass index z
score >1.57) in the early 1990’s, >50% fulﬁlled such criteria
among all clinical referrals for suspected OSA in the last 2–3 years
at our Sleep Center (Gozal et al., 2006). A substantial body of
evidence has accumulated in the last decades to rather conclu-
sively suggest that SDB can lead to substantialmorbidities affecting
CNS, cardiovascular and metabolic systems, and somatic growth,
ultimately leading to signiﬁcant reductions in the quality of life
(Dayyat et al., 2007) Furthermore, it is likely that the concomitant
presence of obesity and OSA will potentiate such morbidities, sug-
gesting that they may be targeting similar cellular substrates whose
dysfunction may underlie the end-organ morbidities seen in SDB
(Bhattacharjee et al., 2011; Spruyt and Gozal, 2012).
CARDIOVASCULAR MORBIDITY OF PEDIATRIC OSA
Similar to adults,OSA in children has now been associated with an
increased risk for cardiovascular morbidities, albeit with reduced
phenotypic severity, most likely the corollary of the better com-
pensatory vascular capacitance in children. For example, increased
prevalence of altered blood pressure regulation (Amin et al., 2004),
systemic hypertension, (Marcus et al., 1998; Enright et al., 2003;
Kohyama et al., 2003), and changes in left ventricular geome-
try, (Amin et al., 2002, 2005), have all now been described in
children with OSA, and appear to be severity-dependent (Aljad-
eff et al., 1997). The mechanisms mediating cardiac and blood
pressure changes are most likely associated with the increases in
sympathetic activity and reactivity that progressively develop in
the context of OSA (Baharav et al., 1999; O’Brien and Gozal,
2005; Hakim et al., 2012). In addition, recent evidence supports
the assumption of potential endothelial dysfunction in children
with OSA, as evidenced by increases in the circulating levels of
several adhesion molecules (O’Brien et al., 2006). Parenthetically,
the endothelial dysfunction associated with OSA is most likely
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the result of initiation and propagation of oxidative stress and
inﬂammatory responses within the microvasculature (Hansson,
2005).
For example, C-reactive protein, which has been traditionally
linked to increased risk for cardiovascular disease even if such
assumption has been recently challenged, (Elias-Smale et al., 2007;
Kovacs et al., 2007) provides a good systemic marker for the
presence of inﬂammation. In a series of recent studies, plasma
concentrations of C-reactive protein were elevated in a severity-
dependent fashion among children and adolescents with OSA,
even after correction for body-mass index (Tauman et al., 2004;
Larkin et al., 2005; Kheirandish-Gozal et al., 2006). Only one study
by Kaditis et al. (2005) failed to identify these relationships in a
study of Greek children.
Therefore, it is highly probable that OSA will elicit a variable,
yet signiﬁcant systemic inﬂammatory response,which in turn may
initiate and propagate atherogenetic mechanisms. In support of
this assumption, three major recent studies from our laboratory
revealed the following:
(1) IL-6 levels were higher and IL-10 plasma levels were lower
in non-obese children with OSA and returned to con-
trol levels after treatment with surgical tonsillectomy and
adenoidectomy (T&A; Gozal et al., 2008b).
(2) Evidence for ﬂow-dependent reperfusion abnormalities
indicative of endothelial dysfunction was identiﬁed in non-
obese children with OSA, and was reversed in most cases after
adenotonsillectomy (T&A; Gozal et al., 2007; see below).
(3) Endothelial dysfunction andneurocognitive deﬁcits are highly
overlapping phenomena in pediatric OSA. Thus, both of these
morbid consequences may share similar pathogenetic mech-
anisms involving the endothelium as the primary process
driving neuronal dysfunction (Gozal et al., 2010).
In the context of the epidemic of childhood obesity, we have also
recently shown that obesity alone elicits endothelial dysfunction,
and that obesity and OSA will interact and potentiate the adverse
functional consequences on the endothelium (Kheirandish-Gozal
et al., 2006; Gozal et al., 2008a).
This is a particularly important issue, since the presence of
early cardiovascular risk factors in childhood has been linked to
decreased survival and increased cardiovascular morbidity later in
life (Berenson et al., 2005).
ALTERATIONS IN ENDOTHELIAL FUNCTION IN
PEDIATRIC OSA
In addition to autonomic nervous system changes, the systemic
inﬂammatory pathways activated in the presence of OSA could
induce functional and structural disruption of the endothelium
(Figure 1). Indeed, reductions in brachial artery ﬂow-mediated
dilation, a surrogate marker of endothelial functional integrity,
have been reported in adults with OSA (Kato et al., 2000; Nieto
et al., 2004; Oﬂaz et al., 2006) and were improved after treatment
with CPAP (Ip et al., 2004; Ohike et al., 2005; Lattimore et al.,
2006).
Similar ﬁndings were also communicated on younger adult
patients with OSA who were free of any known cardiovascular
involvement, and as previously shown, CPAP treatment resulted
in reversal of endothelial dysfunction (Itzhaki and Wertheimer,
1997; Itzhaki et al., 2007).
Endothelial functional changes have also emerged as a frequent
complication of obesity (Suheyl et al., 2005; Bhattacharjee et al.,
2010) anddiabetes (Valle Jimenez et al., 2007),and these are impor-
tant issues considering the increased prevalence of OSA in obese
children (Tauman and Gozal, 2006; Kaditis et al., 2008; Verhulst
et al., 2008, 2009; Bixler et al., 2009; Dayyat et al., 2009) and also
the potential interactions between obesity and OSA to amplify
end-organ dysfunction (Gozal and Kheirandish-Gozal, 2009; Kim
et al., 2010).
I am only aware of a paucity of studies, all of which origi-
nated from our laboratory that have thus far explored whether
OSA adversely impacts on endothelial function in children. The
initial study explored endothelial function in 26 non-obese chil-
dren with OSA using a novel approach to the post-occlusion
hyperemic response test. In this study, endothelial function was
signiﬁcantly impaired when compared to healthy controls. Fur-
thermore, signiﬁcant improvements or complete normalization
of endothelial function occurred 6months after treatment of OSA
with adenotonsillectomy in the majority of the children. However,
the presence of a strong family history of early onset cardiovas-
cular disease in six of the 26 children was associated with no
improvements in endothelial function after adenotonsillectomy
(Gozal et al., 2007).
This observation, if repeated in other cohorts, would position
OSAnot only as amajor trigger for disruption of vascular function
in genetically predisposed children, but also for initiating a cascade
of vascular events in these children that would be more difﬁcult
if not impossible to reverse, leading to earlier onset and increased
severity of cardiovascular diseases during adulthood. In a subse-
quent study, we found that obesity and OSA appear to potentiate
the magnitude of endothelial damage possibly via activation of
systemic inﬂammatory pathways, as evidenced by MRP 8/14 and
CRP levels (Kim et al., 2010).
ENDOTHELIAL PROGENITOR CELLS
Although in pediatric OSA signiﬁcant increases in established
soluble molecules reﬂecting alterations of the main regulatory
functions of the endothelium such as inﬂammation, hemostasis,
or permeability are found, these markers have been somewhat
disappointing by their lack of speciﬁcity and clinical relevance
at the individual level. The capacity of the adherent endothe-
lium to undergo cellular alterations has provided insights on the
endothelium as being a dynamic tissue in equilibrium with a
circulating compartment reﬂecting both lesion and regeneration
of the vascular tree. This endothelial-derived compartment has
led to delineate a third group of cellular markers, correspond-
ing to circulating endothelial cells (CEC) and endothelial-derived
microparticles (EMP) released from the injured vessels and also
progenitors endothelial progenitor cells (EPC).
Described 30 years ago as inert “cellular dust” cell-derived
microparticles (MPs) are considered to be microvesicles (0.05–
1μm) released through the process of exocytic budding of the
plasma membrane following stimulation of different cell types
(Hugel et al., 2005; Nomura et al., 2008).
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FIGURE 1 | Schematic diagram displaying the activation of injurious
pathways in the vasculature as related to OSA.The activation of these
pathways coordinates then a variety of cascades leading to reduced nitric
oxide bioavailability, endothelial damage and dysfunction, shedding of
apoptotic endothelial cells, and migration of monocytes and macrophages to
form foam cells and promote atherosclerosis. In parallel with such events,
release of a variety of chemokines and pro-angiogenic agents, such as VEGF
may be prompted by some subsets of cell-derived microparticles or
exosomes, and may lead to recruitment, migration, and homing to the
damaged endothelium of multiple sub-populations of bone marrow resident
stem cells that have the potential to repair the injured endothelium and either
mitigate or induce a regain of vascular function (green background triangles).
There are two well-known cellular processes that can lead to
the formation of MPs: chemical and physical cell activation (by
agonists or shear stress, respectively), and apoptosis. However,
the mechanisms that take place during MP formation are not
completely elucidated. An asymmetric distribution of phospho-
lipids is generated during membrane biogenesis; this asymmetry
is lost after cell stimulation, and several studies suggest that this is
necessary for MP formation. In normal persons, EMPs represent a
minority of total circulatingMP. Flow cytometry is themostwidely
used method to characterize EMPs, but the pro-coagulant func-
tion of EMP can also be measured using functional assays (based
on coagulation activation by MP derived phospholipids and/or
TF), and these two complementary approaches have been recently
reviewed in a forum aiming to establish standards in measurement
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techniques and reporting methods (Jy et al., 2004; Freyssinet and
Dignat-George, 2005).
Using state-of-the-art consensus approaches we have provided
compelling support to the notion that MP’s are increased in pedi-
atric OSA (Kim et al., 2011), whereby we showed that endothelial
MPs and endothelial progenitor MPs, leukocyte MPs, and platelet
MPs levels are all signiﬁcantly different according to severity of
OSA in children. Furthermore, platelet-derived MPs emerge as
independent contributors to the vascular dysfunction associated
withOSA in children andmay account for increased risk for altered
endothelial function (Kim et al., 2011).
Current understanding supports the view that CEC are mature
cells shed from the vessel wall in response to injury (Blann
et al., 2005).These cells present a heterogeneous size (from 10 to
50 micron), express endothelial markers (von Willebrand factor
[vWF], CD31, CD144) but are negative for leukocyte markers. In
contrast to EPC, they do not express immature markers such as
CD133, and do not give rise to cell colonies with a high prolifer-
ative potential. Due to the extreme scarcity of CEC in peripheral
blood, an important step in their identiﬁcation has been the
development of sensitive technologies for the detection of rare
events based on the immunolabeling with monoclonal antibod-
ies to novel endothelial antigens (George et al., 1991; Woywodt
et al., 2006). In 1992, an antibody recognizing the CD146 antigen
combined with an immuno-magnetic separation assay allowed
the immunological characterization of CEC in the peripheral
blood of patients submitted to coronary angioplasty chosen as
a model of vascular injury. The marked elevation of CEC number
found after angioplasty, conﬁrmed that they result from endothe-
lial trauma triggered by the catheter procedure itself (George et al.,
1992).
Thus, CEC are sensitive indicators of endothelial cell damage,
and could provide important insights into OSA-induced vascular
dysfunction. We are currently unaware of any published studies
on CEC in pediatric OSA.
In 1997, Asahara et al. (1997) initially reported that that puri-
ﬁedCD34positive hematopoietic progenitor cells fromadultswere
able to differentiate ex vivo to an endothelial cell phenotype .
These cells were named “endothelial progenitor cells” (EPC),
and showed expression of various endothelial markers (Asahara
et al., 1997). Circulating EPC have emerged as an important
marker associated with cardiovascular risk proﬁle and physical
ﬁtness (Vasa et al., 2001; Werner et al., 2005).
Endothelial progenitor cells originate from bone marrow stem
cells through a chemokine-dependent gradient involving stromal
differentiation factor 1 (SDF1; also known as CXC chemokine
ligans 12) and its ligand receptor CXC chemokine receptor4
(CXCR4), and such factors appear to be determined not only by
SDF1 gene variation but also by the response to speciﬁc stimuli
such as hypoxia (Aiuti et al., 1997; Benboubker et al., 2001; Moore
et al., 2001; De Falco et al., 2004; Dimmeler and Zeiher, 2004;
Doyle et al., 2006; Werner and Nickenig, 2007; Xiao et al., 2007).
Endothelial progenitor cells are involved in neovessel formation
and endothelial regeneration, with reduced levels and functional
impairment of EPCs being correlated with the presence of coro-
nary artery disease (Benboubker et al., 2001; De Falco et al.,
2004).
Recentwork by Jelic and colleagues has shown thatOSA in adult
patients is not only associated with abnormal endothelial function
and increased inﬂammatory and oxidative stress responses, but is
also accompanied by reduced numbers of circulating EPC. Fur-
thermore, treatment of OSA with CPAP resulted in improvement
of endothelial function and concomitant increases in the number
of circulating EPC (Jelic et al., 2008).
As mentioned above, we have reported on the presence of
endothelial dysfunction on non-obese children with OSA (Gozal
et al., 2007) and that effective treatment of OSA resulted in reversal
of endothelial dysfunction in approximately 80%of these children.
While genetic predisposition of premature cardiovascular disease
could be a factor associated in the lack of improved endothelial
function in these children (Gozal et al., 2007) the possibility exists
that the underlying EPC and SDF1 responses toOSAmay also con-
tribute to endothelial repair. Furthermore, a substantial degree of
variability is present in the time to peak reperfusion after a 60 s-
brachial occlusionmaneuver in childrenwithOSA, suggesting that
themagnitude of endothelial dysfunctionmay be explained at least
in part by the number of circulating EPC (Kheirandish-Gozal et
al., 2010).
SUMMARY
Taken together, a causative link between OSA and endothelial dys-
function in children is likely, and deserves further exploration
including identiﬁcation of mechanisms underlying this potential
morbidity. Based on aforementioned considerations, delineation
of such mechanisms will need to account for processes that medi-
ate injury and also for those that promote vascular repair and
functional integrity (Figure 1). Although the deleterious effects of
OSA on such systems may be reversed by early diagnosis and treat-
ment, the epidemic of childhood obesity is likely to aggravate this
problem, and therefore, improved techniques aiming to establish
the endothelial phenotype in the context of clinical practice need
to be developed, such as to enable risk assessment and optimal
interventions, aiming to prevent the adverse consequences of such
alterations on morbidity and mortality later in life.
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